Aldeyra Therapeutics, Inc.
2019 Q4 - 2025 Q4 (15 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/13/2026 | 88 | 0.0% | 17,021 | 12/31/2025 |
| 2025 Q2 | 8/14/2025 | 77 | 0.0% | 20,074 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 104 | 0.0% | 18,102 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 96 | 0.0% | 19,161 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 112 | 0.0% | 20,693 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 72 | 0.0% | 21,734 | 6/30/2024 |
| 2024 Q1 | 5/14/2024 | 62 | 0.0% | 19,005 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 67 | 0.0% | 19,005 | 12/31/2023 |
| 2023 Q3 | 11/15/2023 | 127 | 0.0% | 19,005 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 159 | 0.0% | 19,005 | 6/30/2023 |
| 2022 Q1 | 8/11/2023 | 100 | 0.0% | 22,492 | 3/31/2022 |
| 2021 Q4 | 2/16/2022 | 111 | 0.0% | 27,645 | 12/31/2021 |
| 2021 Q3 | 11/12/2021 | 238 | 0.0% | 27,061 | 9/30/2021 |
| 2021 Q2 | 8/12/2021 | 320 | 0.0% | 28,251 | 6/30/2021 |
| 2019 Q4 | 2/14/2020 | 89 | 0.0% | 15,284 | 12/31/2019 |